Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

ETR/SHL stock hub

ETR/SHL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/SHLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

37.5B

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/SHL

In the news

Latest news · ETR/SHL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.7

P25 12.3P50 15.7P75 20.2

Trailing P/E18

P25 16.4P50 20.9P75 30.4

ROE11.5

P25 -6.7P50 8.5P75 17.2

ROIC7.4

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/SHL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

230

Groups with data

Currency

EUR

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	73,800
Employees Change	-40%
Employees Change Percent	-0.05
Enterprise value	EUR 51B
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Medical Devices
Isin	DE000SHL1006
Last refreshed	2026-05-10
Market cap	EUR 37.5B
Price	EUR 33.64
Price currency	EUR
Rev Per Employee	311,702.7x
Sector	Healthcare
Sic	3845
Symbol	etr/SHL
Website	https://www.siemens-healthineers.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.58%
EV Earnings	24.34x
EV/EBIT	16.91x
EV/EBITDA	12.51x
EV/FCF	21.02x
EV/Sales	2.21x
FCF yield	6.46%
Forward P/E	13.74x
P/B ratio	2.06x
P/E ratio	18.05x
P/S ratio	1.63x
PE Ratio10 Y	29.59x
PE Ratio3 Y	29.54x
PE Ratio5 Y	30.96x
PEG ratio	1.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.11%
EBITDA Margin	16.8%
FCF margin	10.52%
Gross margin	38.03%
Gross Profit	EUR 8.8B
Gross Profit Growth	-2.24%
Gross Profit Growth Q	-7.79%
Gross Profit Growth3 Y	4.57%
Gross Profit Growth5 Y	8.68%
Net Income	EUR 2.1B
Net Income Growth	0.29%
Net Income Growth Q	-4.53%
Net Income Growth Years	2%
Net Income Growth3 Y	11.31%
Net Income Growth5 Y	5.89%
Pretax Margin	11.94%
Profit Margin	9.08%
Profit Per Employee	EUR 28,311
Profitable Years	11
ROA	4.12
Roa5y	3.95
ROCE	9.47
ROE	11.47
Roe5y	10.88
ROIC	7.43
Roic5y	6.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-26.06%
Cagr3y	-14.52%
Cagr5y	-5.42%
Div CAGR3	1.72%
Div CAGR5	3.3%
EPS Growth	0.2
EPS Growth Q	-4.26
EPS Growth Years	2
EPS Growth3 Y	11.29
EPS Growth5 Y	4.38
FCF Growth	-12.73%
FCF Growth Q	96.97%
FCF Growth3 Y	20.92%
FCF Growth5 Y	3.21%
OCF Growth	-9.03%
OCF Growth Q	45.55%
OCF Growth3 Y	12.78%
OCF Growth5 Y	3.82%
Revenue Growth	-0.33x
Revenue Growth Q	-3.86x
Revenue Growth Years	2x
Revenue Growth3 Y	2.2x
Revenue Growth5 Y	8.96x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.5
Assets	EUR 44.8B
Cash	EUR 1.9B
Current Assets	EUR 14.2B
Current Liabilities	EUR 12.9B
Debt	EUR 15.3B
Debt EBITDA	EUR 3.75
Debt Equity	EUR 0.84
Debt FCF	EUR 6.32
Equity	EUR 18.3B
Interest Coverage	7.4
Liabilities	EUR 26.6B
Long Term Assets	EUR 30.6B
Long Term Liabilities	EUR 13.7B
Net Cash	EUR -13.4B
Net Cash By Market Cap	EUR -35.74
Net Debt EBITDA	EUR 3.46
Net Debt Equity	EUR 0.73
Net Debt FCF	EUR 5.53
Tangible Book Value	EUR -5.6B
Tangible Book Value Per Share	EUR -4.99
WACC	6.73

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.1
Inventory Turnover	3.19
Net Working Capital	EUR 3.3B
Quick ratio	0.66
Working Capital	EUR 1.3B
Working Capital Turnover	EUR 17.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.01%
Dividend Growth	5.26%
Dividend Growth Years	0%
Dividend per share	EUR 1
Dividend Years	8
Dividend Yield	2.97%
Ex Div Date	2026-02-06
Last Dividend	EUR 1
Payout Frequency	Annual
Payout Ratio	53.37%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-26.04%
200-day SMA	43.46
3Y total return	-37.55%
50-day SMA	37.61
50-day SMA vs 200-day SMA	50under200
5Y total return	-24.31%
All Time High	67.66
All Time High Change	-50.28%
All Time High Date	2021-12-09
All Time Low	28.5
All Time Low Change	18.04%
All Time Low Date	2020-03-16
ATR	0.98
Beta	0.8
Beta1y	1.08
Beta2y	1.1
Ch YTD	-25.11
High	33.89
High52	50
High52 Date	2025-07-30
High52ch	-32.72%
Low	33.44
Low52	33.24
Low52 Date	2026-04-30
Low52ch	1.2%
Ma50ch	-10.55%
Price vs 200-day SMA	-22.6%
RSI	32.07
RSI Monthly	30.27
RSI Weekly	30.48
Sharpe ratio	-1.37x
Sortino ratio	-1.47
Total Return	2.96%
Tr YTD	-23.31
Tr1m	-6.4%
Tr1w	-3.53%
Tr3m	-18.74%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 3B
Operating Income Growth	-4.45
Operating Income Growth Q	-13.74
Operating Income Growth3 Y	11.56
Operating Income Growth5 Y	6.44
Operating margin	13.11

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	176,825,834%
Net Borrowing	-1,059,000,000
Shares Institutions	13.08%
Shares Out	1,115,763,718
Shares Qo Q	0.17%
Shares Yo Y	0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 2.4B
Average Volume	1,199,567.4x
Bv Per Share	16.2
CAPEX	EUR -797M
Ch1m	-6.4
Ch1w	-3.53
Ch1y	-27.78
Ch3m	-18.74
Ch3y	-41.15
Ch5y	-31.05
Ch6m	-22.29
Change	-0.85%
Change From Open	-0.36
Close	33.93
Days Gap	-0.5
Depreciation Amortization	850,000,000
Dollar Volume	42,879,192.4
Earnings Date	2026-05-07
EBIT	EUR 3B
EBITDA	EUR 3.9B
EPS	EUR 1.86
F Score	7
FCF	EUR 2.4B
FCF EV Yield	4.76x
FCF Per Share	EUR 2.17
Financing CF	-2,916,000,000
Fiscal Year End	September
Founded	1,896
Goodwill	17,310,000,000
Graham Number	26.29573
Graham Upside	-21.83
Income Tax	EUR 633M
Investing CF	-730,000,000
Is Primary Listing	1
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Lynch Fair Value	EUR 11.05
Lynch Upside	-67.15
Ma150	42.26
Ma150ch	-20.4%
Ma20	36.35
Ma20ch	-7.45%
Net CF	-496,000,000
Next Earnings Date	2026-07-31
Open	33.76
P FCF Ratio	15.47
P OCF Ratio	11.65
Payment Date	2026-02-10
Position In Range	44.44
Ppne	4,840,000,000
Price Date	2026-05-08
Price EBITDA	EUR 9.69
Relative Volume	1.09x
Revenue	23,066,000,000x
Tax By Revenue	2.74x
Tax Rate	22.99%
Tr6m	-20.42%
Volume	1,274,649
Z Score	2

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ETR/SHL dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.0%

$1.00 annual per share

Payout ratio

+53.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+3.3%

0 consecutive years of growth

Total shareholder yield

+3.0%

Next ex-dividend date: 2026-02-06

Performance

ETR/SHL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/SHL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.1%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

ETR/SHL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

32.1

Neutral momentum band

Price vs 200-day MA

-22.6%

50/200-day relationship not available

Beta (5Y)

0.80

Less volatile than the market

Sharpe ratio

-1.37

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/SHL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/SHL stock rating?

etr/SHL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/SHL analysis?

The full report lives at /stocks/etr/SHL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/SHL?

The latest report frames etr/SHL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/SHL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.